Page last updated: 2024-11-03

risperidone and Lymphopenia

risperidone has been researched along with Lymphopenia in 2 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Lymphopenia: Reduction in the number of lymphocytes.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raj, V1
Druitt, T1
Purushothaman, S1
Dunsdon, J1
Assion, HJ1
Kolbinger, HM1
Rao, ML1
Laux, G1

Other Studies

2 other studies available for risperidone and Lymphopenia

ArticleYear
Risperidone/paliperidone induced neutropenia and lymphopenia.
    The Australian and New Zealand journal of psychiatry, 2013, Volume: 47, Issue:3

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Lymphopenia; Male; Middle Aged; Neutropenia; Paliperidone

2013
Lymphocytopenia and thrombocytopenia during treatment with risperidone or clozapine.
    Pharmacopsychiatry, 1996, Volume: 29, Issue:6

    Topics: Adult; Antipsychotic Agents; Clozapine; Humans; Lymphopenia; Male; Risperidone; Thrombocytopenia

1996